Form D · Other
Pillar Biosciences Inc.
Natick, MA · CIK 0001865743
Offering snapshot reported Jun 4, 2021 · SEC filing
- Reported sold
- $20M Offering amount: $50.6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 19, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2021 | Initial | $19,999,998 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-401745
Source: Form D, filed Jun 4, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Forrester | Director |
| Eric Lai | Director |
| Shawn Liu | Director |
| Hong Fang Song | Director |
| Gang Song | Director, Executive |
| Zhaohui Wang | Director |
| Hui Yang | Director |
Issuer details
Industry: Other (See others in industry)
Address:
12 Michigan Dr.
Natick, MA, 01760
Natick, MA, 01760